These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990 [TBL] [Abstract][Full Text] [Related]
23. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis. Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170 [TBL] [Abstract][Full Text] [Related]
24. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures. Froud T; Venkat SR; Barbery KJ; Gunjan A; Narayanan G Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543 [TBL] [Abstract][Full Text] [Related]
25. Characteristics of autoimmune hepatitis in Taiwan: the 11 years' experiences of a medical center. Huang HC; Huang YS; Wu JC; Tsay SH; Huo TI; Wang YJ; Lo JC; Chen CY; Li CP; Chang FY; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 2002 Dec; 65(12):563-9. PubMed ID: 12636201 [TBL] [Abstract][Full Text] [Related]
26. Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis. Banerjee S; Rahhal R; Bishop WP J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):353-6. PubMed ID: 16954959 [TBL] [Abstract][Full Text] [Related]
27. Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use. Ytting H; Larsen FS Scand J Gastroenterol; 2015 Aug; 50(8):1025-31. PubMed ID: 25862144 [TBL] [Abstract][Full Text] [Related]
28. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse. Montano-Loza AJ; Carpenter HA; Czaja AJ Am J Gastroenterol; 2007 May; 102(5):1005-12. PubMed ID: 17319926 [TBL] [Abstract][Full Text] [Related]
29. Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan. Hino T; Kumashiro R; Ide T; Koga Y; Ishii K; Tanaka E; Morita Y; Hisamochi A; Murashima S; Tanaka K; Ogata K; Kuwahara R; Sata M; Int J Mol Med; 2003 Jun; 11(6):749-55. PubMed ID: 12736717 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study. Migita K; Watanabe Y; Jiuchi Y; Nakamura Y; Saito A; Yagura M; Morimoto H; Shimada M; Mita E; Hijioka T; Yamashita H; Takezaki E; Muro T; Sakai H; Nakamuta M; Abiru S; Yano K; Komori A; Yatsuhashi H; Nakamura M; Ishibashi H J Gastroenterol; 2011 Jan; 46 Suppl 1():56-62. PubMed ID: 21042923 [TBL] [Abstract][Full Text] [Related]
31. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869 [TBL] [Abstract][Full Text] [Related]
32. Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes. Aljumah AA; Al-Ashgar H; Fallatah H; Albenmousa A Ann Hepatol; 2019; 18(3):439-444. PubMed ID: 31040094 [TBL] [Abstract][Full Text] [Related]
33. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis. Fung J; Lai CL; Fong DY; Yuen JC; Wong DK; Yuen MF Liver Int; 2008 Dec; 28(10):1408-16. PubMed ID: 18482268 [TBL] [Abstract][Full Text] [Related]
34. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis. Hlivko JT; Shiffman ML; Stravitz RT; Luketic VA; Sanyal AJ; Fuchs M; Sterling RK Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1036-40. PubMed ID: 18586559 [TBL] [Abstract][Full Text] [Related]
35. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients. Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355 [TBL] [Abstract][Full Text] [Related]